share_log

德琪醫藥-B:自願公告 澳門藥物監督管理局批准ATG-010(塞利尼索)用於治療復發性及/或難治性多發性骨髓瘤的新藥上市申請

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF MACAU FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Hong Kong Stock Exchange ·  Dec 6, 2023 03:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more